Fleischhaker C - Search Results

1

Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway.

Walitza S, Wewetzer C, Gerlach M, Klampfl K, Geller F, Barth N, Hahn F, Herpertz-Dahlmann B, Gössler M, Fleischhaker C, Schulz E, Hebebrand J, Warnke A, Hinney A. Walitza S, et al. Among authors: fleischhaker c. J Neural Transm (Vienna). 2004 Jul;111(7):817-25. doi: 10.1007/s00702-004-0134-y. Epub 2004 Apr 13. J Neural Transm (Vienna). 2004. PMID: 15206000

2

Determination of clozapine and its major metabolites in serum samples of adolescent schizophrenic patients by high-performance liquid chromatography. Data from a prospective clinical trial.

Schulz E, Fleischhaker C, Remschmidt H. Schulz E, et al. Among authors: fleischhaker c. Pharmacopsychiatry. 1995 Jan;28(1):20-5. doi: 10.1055/s-2007-979583. Pharmacopsychiatry. 1995. PMID: 7746841

3

[Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].

Schulz E, Remschmidt H, Fleischhaker C. Schulz E, et al. Among authors: fleischhaker c. Z Kinder Jugendpsychiatr. 1994 Dec;22(4):285-98. Z Kinder Jugendpsychiatr. 1994. PMID: 7856324 German.

4

Schulz E, Fleischhaker C, Remschmidt HE. Schulz E, et al. Among authors: fleischhaker c. J Child Adolesc Psychopharmacol. 1996 Summer;6(2):119-31. doi: 10.1089/cap.1996.6.119. J Child Adolesc Psychopharmacol. 1996. PMID: 9231304 Clinical Trial.

5

Serum leptin levels increase rapidly after initiation of clozapine therapy.

Brömel T, Blum WF, Ziegler A, Schulz E, Bender M, Fleischhaker C, Remschmidt H, Krieg JC, Hebebrand J. Brömel T, et al. Among authors: fleischhaker c. Mol Psychiatry. 1998 Jan;3(1):76-80. doi: 10.1038/sj.mp.4000352. Mol Psychiatry. 1998. PMID: 9491817

6

Blood biogenic amines during clozapine treatment of early-onset schizophrenia.

Schulz E, Fleischhaker C, Clement HW, Remschmidt H. Schulz E, et al. Among authors: fleischhaker c. J Neural Transm (Vienna). 1997;104(10):1077-89. doi: 10.1007/BF01273320. J Neural Transm (Vienna). 1997. PMID: 9503259 Clinical Trial.

7

Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia.

Fleischhaker C, Schulz E, Remschmidt H. Fleischhaker C, et al. J Psychiatr Res. 1998 Sep-Oct;32(5):325-33. doi: 10.1016/S0022-3956(98)00012-0. J Psychiatr Res. 1998. PMID: 9789212

8

[Depressive symptoms and biogenic amines as predictors of treatment response in schizophrenic illnesses in childhood and adolescence].

Fleischhaker C, Schulz E, Remschmidt H. Fleischhaker C, et al. Z Kinder Jugendpsychiatr Psychother. 1998 Dec;26(4):235-43. Z Kinder Jugendpsychiatr Psychother. 1998. PMID: 9880833 German.

9

Management of schizophrenia in children and adolescents. The role of clozapine.

Remschmidt H, Fleischhaker C, Hennighausen K, Schulz E. Remschmidt H, et al. Among authors: fleischhaker c. Paediatr Drugs. 2000 Jul-Aug;2(4):253-62. doi: 10.2165/00128072-200002040-00002. Paediatr Drugs. 2000. PMID: 10946414 Review.

10

[Psychotic disorders and drug abuse in adolescents].

Fleischhaker C, Priemer K, Schulz E, Remschmidt H. Fleischhaker C, et al. Z Kinder Jugendpsychiatr Psychother. 2002 May;30(2):87-95. doi: 10.1024//1422-4917.30.2.87. Z Kinder Jugendpsychiatr Psychother. 2002. PMID: 12053878 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters